Your search returned over 250 studies. The top 250 studies are being displayed. Please use additional keywords or decrease the search distance. Get alerts for new studies
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Billings, Montana
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Billings, Montana
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Billings, Montana
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Billings, Montana
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Patients Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metas
Conditions: Metastatic Cancer - Prostate Cancer
Location: Billings, Montana
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Billings, Montana
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Billings, Montana
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Billings, Montana
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Billings, Montana
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
Location: Billings, Montana
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Billings, Montana
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Billings, Montana
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Billings, Montana
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Billings, Montana
- Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Conditions: Colorectal Cancer
Location: Billings, Montana
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Azacitidine With or Without Entinostat in Treating Patients With Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia
Conditions: Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Billings, Montana
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Billings, Montana
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Billings, Montana
- Irinotecan, Oxaliplatin, and Capecitabine as First-Line Therapy in Treating Patients With Metastatic or Unresectable Locally Advanced Small Bowel Canc
Conditions: Small Intestine Cancer
Location: Billings, Montana
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib and Bevacizumab in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Tamoxifen or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease
Conditions: Diabetic Type 1 With Obstructive Pulmonary Disease - Diabetic Type 2 With Obstructive Pulmonary Disease - Asthma - COPD - Diabetes Mellitus, Insulin-Dependent - Diabetes Mellitus, Non-Insulin-Dependent - Indeterminate Obstructive Lung Disease
Location: Billings, Montana
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Azacitidine and Gemtuzumab in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Erlotinib With or Without Carboplatin and Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Billings, Montana
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Billings, Montana
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Billings, Montana
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Billings, Montana
- Capecitabine and Lapatinib With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB, Stage IIIC, or Stage IV
Conditions: Breast Cancer
Location: Billings, Montana
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Billings, Montana
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Billings, Montana
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Billings, Montana
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemot
Conditions: Lung Cancer
Location: Billings, Montana
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Billings, Montana
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Billings, Montana
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Billings, Montana
- Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery
Conditions: Malignant Mesothelioma
Location: Billings, Montana
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Billings, Montana
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Billings, Montana
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Billings, Montana
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Billings, Montana
- Paclitaxel, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or
Conditions: Breast Cancer
Location: Billings, Montana
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Topotecan With or Without Aflibercept in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Idarubicin, Cytarabine, and Pravastatin in Treating Patients With Relapsed Acute Myeloid Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
Conditions: Anemia - Leukemia - Myelodysplastic Syndromes
Location: Billings, Montana
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Billings, Montana
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Billings, Montana
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Billings, Montana
- Acute Pain Caused by Paclitaxel in Patients With Cancer
Conditions: Chemotherapeutic Agent Toxicity - Neurotoxicity - Pain - Unspecified Adult Solid Tumor, Protocol Specific
Location: Billings, Montana
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Billings, Montana
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Billings, Montana
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Billings, Montana
- Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Conditions: Liver Cancer
Location: Billings, Montana
- Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Observation or Radiation Therapy in Treating Patients With Grade I, Grade II, or Grade III Meningioma
Conditions: Brain and Central Nervous System Tumors
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary
Conditions: Carcinoma of Unknown Primary
Location: Billings, Montana
- Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Epratuzumab, Cytarabine, and Clofarabine in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- A Study of Single-Agent Eribulin Mesylate as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2)
Conditions: Locally Recurrent or Metatastic Breast Cancer ( HER2 Negative)
Location: Billings, Montana
- Insulin Resistance Intervention After Stroke Trial
Conditions: Stroke - Myocardial Infarction - Diabetes
Location: Billings, Montana
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Billings, Montana
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Billings, Montana
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Billings, Montana
- Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Tri
Conditions: Breast Cancer
Location: Billings, Montana
- Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
Conditions: Lung Cancer
Location: Billings, Montana
- EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer
Conditions: Neoplasms, Breast
Location: Billings, Montana
- Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
Conditions: Breast Cancer - Cognitive/Functional Effects - Lung Cancer - Metastatic Cancer - Prostate Cancer
Location: Billings, Montana
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Billings, Montana
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Billings, Montana
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Billings, Montana
- Octreotide and Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
Conditions: Neuroendocrine Carcinoma
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Billings, Montana
- Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Conditions: Head and Neck Cancer
Location: Billings, Montana
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
Conditions: Multiple Myeloma and Plasma Cell Neoplasm
Location: Billings, Montana
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Billings, Montana
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Billings, Montana
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Billings, Montana
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Conditions: Breast Cancer
Location: Billings, Montana
- Welchol as Add-on to Pioglitazone Therapy for Type 2 Diabetes Mellitus
Conditions: Type 2 Diabetes Mellitus
Location: Billings, Montana
- Sitagliptin Cardiovascular Outcome Study (0431-082 AM1)
Conditions: Type 2 Diabetes Mellitus
Location: Billings, Montana
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Billings, Montana
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Billings, Montana
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Billings, Montana
- Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
Conditions: Cervical Cancer
Location: Billings, Montana
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Billings, Montana
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II End
Conditions: Endometrial Cancer - Fatigue - Neurotoxicity
Location: Billings, Montana
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Billings, Montana
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Billings, Montana
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Billings, Montana
- Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy and G-CSF in Treating Patients With Stage III
Conditions: Lymphoma
Location: Billings, Montana
- Tumor Marker YKL-40 in Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian T
Conditions: Fallopian Tube Cancer - Ovarian Cancer - Primary Peritoneal Cavity Cancer
Location: Billings, Montana
- PAVES: Pegfilgrastim Anti-VEGF Evaluation Study
Conditions: Cancer - Colon Cancer - Colorectal Cancer - Fever - Locally Advanced - Metastatic Colorectal Cancer - Neutropenia - Rectal Cancer
Location: Billings, Montana
- Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer
Conditions: Metastatic Breast Cancer
Location: Billings, Montana
- A Study to Evaluate Corrected QT Interval and Drug-Drug Interaction of Trastuzumab on Carboplatin in the Presence of Docetaxel in Patients With HER2-P
Conditions: Solid Cancers
Location: Billings, Montana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Billings, Montana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Billings, Montana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Billings, Montana
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endome
Conditions: Endometrial Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Billings, Montana
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Billings, Montana
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Billings, Montana
- Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
Conditions: Ovarian Cancer - Sarcoma
Location: Billings, Montana
- Continued HER2 Suppression With Lapatinib Plus Trastuzumab Versus Trastuzumab Alone
Conditions: Adenocarcinoma - Her2+ - Advanced Metastatic Breast Cancer - Metastatic ErbB2 - Invasive Breast Cancer - Advanced Breast Cancer - Cancer - ErbB2+
Location: Billings, Montana
- Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Lymphoma
Location: Billings, Montana
- Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Lymphoma
Location: Billings, Montana
- Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Lymphoma
Location: Billings, Montana
- Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Lymphoma
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Billings, Montana
- Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Conditions: Melanoma (Skin)
Location: Billings, Montana
- Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma, B-Cell
Location: Billings, Montana
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Billings, Montana
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Billings, Montana
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Billings, Montana
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
Conditions: Colorectal Cancer - Precancerous Condition
Location: Billings, Montana
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Rituximab and Alemtuzumab in Treating Older Patients With Progressive Chronic Lymphocytic Leukemia
Conditions: Leukemia
Location: Billings, Montana
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
Conditions: Lung Cancer
Location: Billings, Montana
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Billings, Montana
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Billings, Montana
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Billings, Montana
- Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute M
Conditions: Leukemia
Location: Billings, Montana
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Billings, Montana
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Billings, Montana
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Billings, Montana
- Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Canc
Conditions: Lung Cancer
Location: Billings, Montana
- A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus
Conditions: Diabetes Mellitus, Type 2
Location: Billings, Montana
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Fallopian Tube Cancer - Ovarian Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Fallopian Tube Cancer - Ovarian Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Fallopian Tube Cancer - Ovarian Cancer
Location: Billings, Montana
- Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnos
Conditions: Fallopian Tube Cancer - Ovarian Cancer
Location: Billings, Montana
- A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Conditions: Head and Neck Neoplasms
Location: Billings, Montana
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Billings, Montana
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Billings, Montana
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Billings, Montana
- Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung
Conditions: Lung Cancer
Location: Billings, Montana
- Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Bicalutamide and Goserelin or Leuprolide Acetate With or Without Cixutumumab in Treating Patients With Newly Diagnosed Metastatic Prostate Cancer
Conditions: Prostate Cancer
Location: Billings, Montana
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Billings, Montana
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Billings, Montana
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Billings, Montana
- Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Conditions: Kidney Cancer
Location: Billings, Montana
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Tamoxifen Citrate in Treating Patients With Metastatic or Recurrent Breast Cancer
Conditions: Breast Cancer
Location: Billings, Montana
- Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)
Conditions: Acute Coronary Syndrome
Location: Billings, Montana
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Billings, Montana
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Billings, Montana
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Billings, Montana
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With S
Conditions: Colorectal Cancer
Location: Billings, Montana
- Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Head and Neck Cancer - Mucositis - Oral Complications of Radiation Therapy - Pain
Location: Billings, Montana
- Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Head and Neck Cancer - Mucositis - Oral Complications of Radiation Therapy - Pain
Location: Billings, Montana
- Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Head and Neck Cancer - Mucositis - Oral Complications of Radiation Therapy - Pain
Location: Billings, Montana
- Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Conditions: Head and Neck Cancer - Mucositis - Oral Complications of Radiation Therapy - Pain
Location: Billings, Montana
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
Location: Billings, Montana
- A Phase 1 Study of 1-MT in Combination With Docetaxel in Metastatic Solid Tumors
Conditions: Solid Tumor
Location: Billings, Montana
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Billings, Montana
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Billings, Montana
- Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Conditions: Diarrhea - Gastrointestinal Complications - Unspecified Adult Solid Tumor, Protocol Specific
Location: Billings, Montana
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Billings, Montana
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Billings, Montana
- Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
Conditions: Kidney Cancer
Location: Billings, Montana
|